Sequenom to launch public stock offering
Biotech company Sequenom Inc. said Wednesday it intends to mount an underwritten public offering of its common stock.
The company didn't specify the size of the offering.
Jefferies & Company Inc. is the sole book-running manager for the offering.
Shares fell 55 cents, or 8.1 percent, to $6.26 in aftermarket trading after slipping 5 cents to $6.81 during the regular session.